Literature DB >> 20922392

Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer.

Vicky Goh1, Manu Shastry, Alec Engledow, Jonathan Reston, David M Wellsted, Jacqui Peck, Raymondo Endozo, Manuel Rodriguez-Justo, Stuart A Taylor, Steve Halligan, Ashley M Groves.   

Abstract

OBJECTIVE: To determine how commercial software platform upgrades impact on derived parameters for colorectal cancer.
MATERIALS AND METHODS: Following ethical approval, 30 patients with suspected colorectal cancer underwent Perfusion CT using integrated 64 detector PET/CT before surgery. Analysis was performed using software based on modified distributed parameter analysis (Perfusion software version 4; Perfusion 4.0), then repeated using the previous version (Perfusion software version 3; Perfusion 3.0). Tumour blood flow (BF), blood volume (BV), mean transit time (MTT) and permeability surface area product (PS) were determined for identical regions-of-interest. Slice-by-slice and 'whole tumour' variance was assessed by Bland-Altman analysis.
RESULTS: Mean BF, BV and PS was 20.4%, 59.5%, and 106% higher, and MTT 14.3% shorter for Perfusion 4.0 than Perfusion 3.0. The mean difference (95% limits of agreement) were +13.5 (-44.9 to 72.0), +2.61 (-0.06 to 5.28), -1.23 (-6.83 to 4.36), and +14.2 (-4.43 to 32.8) for BF, BV, MTT and PS respectively. Within subject coefficient of variation was 36.6%, 38.0%, 27.4% and 60.6% for BF, BV, MTT and PS respectively indicating moderate to poor agreement.
CONCLUSION: Software version upgrades of the same software platform may result in significantly different parameter values, requiring adjustments for cross-version comparison.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922392     DOI: 10.1007/s00330-010-1967-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

1.  Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.

Authors:  D Gandhi; D B Chepeha; T Miller; R C Carlos; C R Bradford; R Karamchandani; F Worden; A Eisbruch; T N Teknos; G T Wolf; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

2.  Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.

Authors:  Douglas G McNeel; Jens Eickhoff; Fred T Lee; David M King; Dona Alberti; James P Thomas; Andreas Friedl; Jill Kolesar; Rebecca Marnocha; Jennifer Volkman; Jianliang Zhang; Luz Hammershaimb; James A Zwiebel; George Wilding
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

3.  Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon.

Authors:  Chaan S Ng; Xiaohong Wang; Silvana C Faria; E Lin; Chusilp Charnsangavej; Nizar M Tannir
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

4.  A model for capillary exchange.

Authors:  J A Johnson; T A Wilson
Journal:  Am J Physiol       Date:  1966-06

5.  Quantitative tumor perfusion assessment with multidetector CT: are measurements from two commercial software packages interchangeable?

Authors:  Vicky Goh; Steve Halligan; Clive I Bartram
Journal:  Radiology       Date:  2007-03       Impact factor: 11.105

6.  Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?

Authors:  Vicky Goh; Steve Halligan; Frances Daley; David M Wellsted; Thomas Guenther; Clive I Bartram
Journal:  Radiology       Date:  2008-09-23       Impact factor: 11.105

7.  Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer.

Authors:  Koichi Hayano; Kiyohiko Shuto; Keiji Koda; Noriyuki Yanagawa; Shinichi Okazumi; Hisahiro Matsubara
Journal:  Dis Colon Rectum       Date:  2009-09       Impact factor: 4.585

8.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

9.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

10.  Difference in tracer delay-induced effect among deconvolution algorithms in CT perfusion analysis: quantitative evaluation with digital phantoms.

Authors:  Kohsuke Kudo; Makoto Sasaki; Kuniaki Ogasawara; Satoshi Terae; Shigeru Ehara; Hiroki Shirato
Journal:  Radiology       Date:  2009-02-03       Impact factor: 11.105

View more
  9 in total

Review 1.  Standardising measurement of tumour vascularity by imaging: recommendations for ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography.

Authors:  Adrian K Dixon; Fiona J Gilbert
Journal:  Eur Radiol       Date:  2012-04-29       Impact factor: 5.315

2.  Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors.

Authors:  Chaan S Ng; Adam G Chandler; James C Yao; Delise H Herron; Ella F Anderson; Chusilp Charnsangavej; Brian P Hobbs
Journal:  J Comput Assist Tomogr       Date:  2014 Jul-Aug       Impact factor: 1.826

3.  The role of acquisition and quantification methods in myocardial blood flow estimability for myocardial perfusion imaging CT.

Authors:  Brendan L Eck; Raymond F Muzic; Jacob Levi; Hao Wu; Rachid Fahmi; Yuemeng Li; Anas Fares; Mani Vembar; Amar Dhanantwari; Hiram G Bezerra; David L Wilson
Journal:  Phys Med Biol       Date:  2018-09-13       Impact factor: 3.609

4.  Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.

Authors:  Gian Marco Conte; Antonella Castellano; Luisa Altabella; Antonella Iadanza; Marcello Cadioli; Andrea Falini; Nicoletta Anzalone
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

5.  Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.

Authors:  Jill Rachel Mains; Frede Donskov; Erik Morre Pedersen; Hans Henrik Torp Madsen; Jesper Thygesen; Kennet Thorup; Finn Rasmussen
Journal:  Br J Radiol       Date:  2018-01-02       Impact factor: 3.039

6.  Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values.

Authors:  Chaan S Ng; Brian P Hobbs; Adam G Chandler; Ella F Anderson; Delise H Herron; Chusilp Charnsangavej; James Yao
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

7.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

8.  Comparison of automated beam hardening correction (ABHC) algorithms for myocardial perfusion imaging using computed tomography.

Authors:  Jacob Levi; Hao Wu; Brendan L Eck; Rachid Fahmi; Mani Vembar; Amar Dhanantwar; Anas Fares; Hiram G Bezerra; David L Wilson
Journal:  Med Phys       Date:  2020-12-07       Impact factor: 4.506

9.  Variability and Reproducibility of 3rd-generation dual-source dynamic volume perfusion CT Parameters in Comparison to MR-perfusion Parameters in Rectal Cancer.

Authors:  Sonja Sudarski; Thomas Henzler; Teresa Floss; Tanja Gaa; Mathias Meyer; Holger Haubenreisser; Stefan O Schoenberg; Ulrike I Attenberger
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.